SynthesisCancer2017

Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials.

Wendy B London et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.